LexDanaLexDanabeta
Inventor

John Robert Pollard

Inventor
Abingdon, GB

Overview

7→
Patents
2015–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 7 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
G01NInvestigating or analysing materials by determining their chemical or physical properties36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
A61NElectrotherapy7%
C07DHeterocyclic compounds7%
PatentTitleYear
11,035,866Biomarkers for seizures202110,813,929Treating cancer with ATR inhibitors202010,478,430Compounds useful as inhibitors of ATR kinase and combination therapies thereof20199,983,219Biomarkers for seizures20189,791,456'Method for measuring ATR inhibition mediated increases in DNA damage'20179,772,335'Biomarkers for seizures'20178,999,632'Method for measuring ATR inhibition mediated increases in DNA damage'2015

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2015–2020Patents assigned to VERTEX PHARMA (4)· patent assignee history
2015–2017Patents assigned to UNIV NEWCASTLE (2)· patent assignee history
2015–2020Based in Abingdon, GB· patent location history
2017–2021Patents assigned to UNIV PENNSYLVANIA (3)· patent assignee history
2017–2021Based in Wallingford, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
VERTEX PHARMA42015–2020
UNIV PENNSYLVANIA32017–2021
UNIV NEWCASTLE22015–2017
Locations
LocationPatentsSpan
Abingdon, GB42015–2020
Wallingford, Pennsylvania, US32017–2021